RSS Newsfeeds

See all RSS Newsfeeds

Global Regions

Europe ( XML Feed )

Aug 16, 2016 2:30 PM ET

Archived: Relavance Software S.A. was formed to consolidate all IP, Rights and Source codes to a patented software technology totally based on Associative Memory

iCrowdNewswire - Aug 16, 2016



Eysins, 1262, Switzerland
Packaged Software

Relavance Software S.A. (RSSA) was formed to consolidate all IP, Rights and Source codes to a patented software technology totally based on Associative Memory. The patent was approved on Nevember 1st, 2011 after a 5-year law suit against the US Patent Office. RSSA has, based on the Associative Memory technology, also developed a platform to develop new applications easier and faster than any software before. The mission is to revolutionize the software industry with this dynamic technology.
RSSA has now developed a new application that captures compliance activites and automates much of the compliance procedures in companies and other entities. All activities are represented in a dash board that can be zoomed, to user’s need of details and view, based upon a managed authorization process. RSSA intends to form a separate business entity to market the Compliance Activity Managment System -CAMS with special focus on the Life Science industry.
The mission is to reduce compliance risk and enhance productivity by integrating CAMS in the company processees instead of making it a special procedure that just fullfiils the regulations and authorities.

Products / Services


Via a dashboard, authorized users can see current status of their compliance from virtually any angle in summary or detail
– regulation
– deadline
– regulatory authority
– department
– location
– responsible manager
– any combination of any such perspective



Chief Technology Officer
Ron Everett

Inventor of the Associative Memory Technology with patent approved November 1, 2011.
Inventor of the compliance activity management system and filed provisional patent in April of 2012

Chief Operating Officer
Gilles Favey

Gilles founded Relavance Europe in 2008 and currently assume the role of CIO/COO.
Prior to joining Relavance SA, he worked as CTO of Nanolife and before that he was Senior developer and Project Manager at Swissquote / Marvel.
Gilles has over 15 year of IT experience, including a broad range of leadership roles at Dun and Bradstreet, MMD / Namics, he has demonstrated high level of expertise in project & implementation management and database development.
Gilles graduated from the Swiss Federal Institute of Technology (EPFL) in Lausanne in 1993 and from Swiss Media in 2001.

Chief Financial Officer
Jan Meijer

1971 M. started carrier in a Swedish ferry line at the age of 24 and became CEO of Ferry line between Sweden and Denmark at age 29.
1980 M. moved to USA as corporate controller for the Swedish conglomerate Bonnier Group’s US operation.
1984 M. started own consulting business and was engaged as controller for a Swedish start-up concrete operation in Atlanta 1985.
1987 M. was engaged as the CEO of the concrete operation, which was named Thomas Concrete.
2002 M. left the company when it had 43 plants in Georgia, South and North Carolina and 600 Ready mix trucks as well as an import terminal of cement in Charleston. Revenues topped $220 million 2001.
2002 M. made an investment in Relavance.
2008 -2010 M. was engaged as an investor and a turn-around agent for a Precast Concrete company.
1994 – 2000 M. was either the Chairman or Board Member of Swedish-American Chamber of Commerce in Atlanta
1999 – 2003 M. was the Swedish Consul for the State of Georgia

Acting/Interim Business Development
Tomas Svoboda

Corporate, technical and field experience in the Life Science Industry (med-tech, diagnostics
and drug-delivery) as well as technology companies (electronic sub-assemblies for life science
applications) acquired in large and midsize corporations as well as in start-ups over the past 26
years working in 6 countries (CH, UK, US, D, A, F)
· In depth hands on experience in:
• Business development in Life Science industry – strategic partner search,
negotiations and contractual agreement, market entry mapping & strategies,
• Management of small and mid-sized profit centers in the Life Science industry
• Regulatory affairs and quality system – set-up, approval and management
· Worked and lived in several countries with various product lines and LS companies
· Operating in objective and budget defined structures to establish or develop new entities.

Acting/Interim Business Development
Ernie Riddle

Riddle is the Co Founder and Former President/CEO of Astadia, Inc. in Atlanta, GA, a “Cloud Computing/SaaS” Consulting and Systems Integration Company. He grew the company to $30M with operations in the US, EMEA, India and APAC. He lead the company thru three rounds of funding totaling more than $16M, and secured premier partner relationships with software companies including salesforce.com, Xactly, Eloqua, Google, Cornerstone and Workday.
Previously, he served as President and Chief Operating Officer of Norrell Services, Inc., a $1.6B outsourcing, information technology services. He was responsible for operations, sales and marketing and strategic planning for the United States, Canada, and the European expansion.
Riddle began his career at Xerox Corporation, where he held a variety of senior management roles during his 25-year tenure, including Vice President of Marketing in the United States and Europe, and Vice President of Sales & Sales Operations for the U.S. Group.

Acting/Interim Business Development
Patricia L. Olinger

Mrs Olinger serves as the director for Environmental, Health and Safety at Emory University in Atlanta since 9/2006.This includes day to day management of 43 EHS professionals, technicians and administrative staff with direct budget oversight of $3.6 million. At Emory Mrs. Olinger is leading the implementation of an integrated EHS Management System. Guidance found in CWA 15793:2007, ISO 14001 and OHSAS 18001 are being adopted.
During 2006 she served as E,H&S Lead at the Pfizer R&D in Kalamazoo including Bio-safety and Chemical hygiene.
2003 -2005 Associate director Pfizer Kalamazoo R7D/Animal Health EHS.
1992- 2003 R&D EHS manager – providing Safety Program and management support to R&D for Bio-safety and Laboratory Safety Guidance both to Human Health and Animal Health divisions.
1985 – 1992 Research Biochemist, Cell Biology Department, Biotechnology, The Upjohn Company in Kalamzoo


Prior Year Revenue Current Year Revenue Next Year Revenue


Company Age Employees Sub-Industry
4 years, 6 months 14 Miscellaneous Business Software


Company Type Stock Exchange Stock Symbol
Contact Information:

Jan Meijer

View Related News >